Frailty in patients with interstitial lung disease

Area of Science:

• Gerontology
• Pulmonology
• Clinical Medicine

Background:

• Rising incidence of age-related diseases like interstitial lung disease (ILD).
• Increasing recognition of multimorbidity and health deficits in chronic lung diseases.
• Aging and ILD share demographic and biological connections, with frailty representing declining physiological reserves.

Purpose of the Study:

• To review the impact of frailty in patients with interstitial lung disease (ILD).
• To explore the relationship between aging, frailty, and ILD.
• To identify potential management strategies for frailty in the context of ILD.

Main Methods:

• Review of current literature on frailty and ILD.
• Analysis of factors contributing to frailty in ILD patients.
• Examination of frailty as a risk factor for adverse outcomes.

Main Results:

• Frailty affects over 50% of ILD patients.
• Key contributors include respiratory impairment, accelerated aging, comorbidities, medication side effects, and social factors.
• Frailty is an independent predictor of hospitalization and mortality, pre- and post-lung transplant.

Conclusions:

• Frailty is a significant risk factor for adverse outcomes in ILD.
• Optimal assessment tools and preventative/counteractive strategies for frailty in aging ILD populations require further research.
• Pulmonary rehabilitation is a promising approach for managing frailty due to its multicomponent determinants.